All stock lists
Unlock the score
ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
17.89+0.27 (+1.50%)
Insider Score
/ 100
ADRX Insider Score
ADARx Pharmaceuticals, Inc. has a live Insider Score.
Scored on 10 qualifying trades from 4 insiders in the last 90 days.
ADRX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 746.00 K | 2.14 M | 208.00 K | 0.00 |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| SG&A Expense | 5.90 M | 5.62 M | 4.26 M | 5.00 M |
| R&D Expense | 24.74 M | 23.58 M | 17.07 M | 12.89 M |
| Operating Expenses | 30.64 M | 29.20 M | 21.33 M | 17.89 M |
| Operating Income | -29.89 M | -27.06 M | -21.12 M | -17.89 M |
| Pretax Income | -25.76 M | -22.67 M | -18.09 M | -15.55 M |
| Tax Provision | — | — | — | — |
| Net Income | -25.76 M | -22.67 M | -18.09 M | -15.55 M |
| EPS (Basic) | — | -0.22 | — | -0.21 |
| EPS (Diluted) | — | -0.22 | — | -0.21 |
| Shares Outstanding | — | 102.20 M | — | 75.31 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.